Microbial deprivation, inflammation and cancer

Cancer and Metastasis Reviews

Volumn 30, Issue 2, 2011, Pages 211-223

  Von Hertzen, Leena C ^a   Joensuu, H ^b   Haahtela, T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cancer; Environment; Hygiene hypothesis; IL 23; Inflammation; Microbes; Th17

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 23; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR; AUTACOID; CYTOKINE;

ANGIOGENESIS; CANCER GROWTH; CANCER RISK; CHRONIC INFLAMMATION; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; TUMOR GROWTH; BIOLOGICAL MODEL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NEOPLASM;

CYTOKINES; ENVIRONMENTAL MICROBIOLOGY; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MODELS, IMMUNOLOGICAL; NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 79960977522     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9284-1     Document Type: Review

References (120)

1. von Hertzen, L. C., Savolainen, J., Hannuksela, M., Klaukka, T., Lauerma, A., Mäkelä, M. J., et al. (2009). Scientific rationale for the Finnish Allergy Programme 2008-2018. Allergy, 64, 678-701.
2. Rook, G. A. W., Adams, V., Hunt, J., Palmer, R., Martinelli, R., & Rosa Brunet, L. (2004). Mycobacteria and other environmental organisms as immunomodulators for immunoreglatory disorders. Springer Semin Immunopathol, 25, 237-255. (Pubitemid 38296934)
3. Klein, G. (2002). Perspectives in studies of human tumor viruses. Frontiers in Bioscience, 7, d268-d274.
4. Coley, W. B. (1893). The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. The American Journal of the Medical Sciences, 105, 487-511.
5. Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008). Cancer-related inflammation. Nature, 454, 436-444.
6. Enterline, P. E., Sykora, J. L., Keleti, G., & Lange, J. H. (1985). Endotoxin, cotton dust, and cancer. Lancet, 2, 934-935.
7. Rylander, R. (1009). Environmental exposures with decreased risks for lung cancer. International Journal of Epidemiology, 19, 567-572.
8. Mastrangelo, G., Marzia, V., & Marcer, G. (1996). Reduced lung cancer mortality in dairy farmers: Is endotoxin exposure the key factor? American Journal of Industrial Medicine, 30, 601-609. (Pubitemid 26372544)
9. Rapiti, E., Sperati, A., Fano, V., Dell'orco, V., & Forastiere, F. (1997). Mortality among workers at municipal waste incinerators in Rome: A retrospective cohort study. American Journal of Industrial Medicine, 31, 659-661. (Pubitemid 27154750)
10. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004). Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell, 118, 229-241. (Pubitemid 38962578)
11. Bollky, P. L., Bice, J. B., Sweet, I. R., Falk, B. A., Gebe, J. A., Clark, A. E., et al. (2009). The Toll-like receptor signalling molecule Myd88 contributes to pancreatic beta-cell homeostasis response to injury. PLoS ONE, 4, e5063.
12. Macedo, L., Pinhal-Enfield, G., Alshits, V., Elson, G., Cronstein, B. N., & Leibovich, S. J. (2007). Wound healing is impaired in MyD88-deficient mice. The American Journal of Pathology, 171, 1774-1788.
13. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., et al. (2005). Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Natural Medicines, 11, 1173-1179. (Pubitemid 43093664)
14. Seki, E., Tsutsui, H., Iimuro, Y., Naka, T., Son, G., Akira, S., et al. (2005). Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology, 41, 443-450. (Pubitemid 40289490)
15. Beachy, P. A., Karhadkar, S. S., & Berman, D. M. (2004). Tissue repair and stem cell renewal in carcino-genesis. Nature, 432, 324-331. (Pubitemid 39551660)
16. Balkwill, F., & Mantovani, A. (2001). Inflammation and cancer: Back to Virchow? Lancet, 357, 539-545. (Pubitemid 32173595)
17. Vesterinen, E., Pukkala, E., Timonen, T., & Aromaa, A. (1993). Cancer incidence among 78, 000 asthmatic patients. International Journal of Epidemiology, 22, 976-982. (Pubitemid 24025673)
18. Rubio, C. A., Kapraali, M., & Befrits, R. (2009). Further studies on the frequency of colorectal cancer in Crohn's colitis: An 11- year survey in the Northwest Stockholm County. Anticancer Research, 29, 4291-4295.
19. Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009). Prostanoids in health and disease. Journal of Lipid Research, 50, S423-S428.
20. Wang, M. T., Honn, K. V., & Nie, D. (2007). Cyclooxygenases, prostanoids, and tumor progression. Cancer and Metastasis Reviews, 26, 525-534. (Pubitemid 350115125)
21. Vakkila, J., & Lotze, M. T. (2004). Inflammation and necrosis promote tumour growth. Nature Reviews. Immunology, 4, 641-648. (Pubitemid 39025049)
22. Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature, 454, 428-435.
23. Mantovani, A. (2005). Cancer: Inflammation by remote control. Nature, 435, 752-753. (Pubitemid 40839716)
24. Kuper, H., Adami, H. O., & Trichopoulos, D. (2000). Infections as a major preventable cause of human cancer. J Int Med, 248, 171-183. (Pubitemid 33702479)
25. Laakkonen, A., & Pukkala, E. (2008). Cancer incidence among Finnish farmers 1995-2005. Scandinavian Journal of Work, Environment & Health, 34, 73-79. (Pubitemid 351585730)
26. Mastrangelo, G., Grange, J. M., Fadda, E., Fedeli, U., Buja, A., & Lange, J. H. (2005). Lung cancer risk: Effect of dairy farming and the consequence of removing that occupational exposure. American Journal of Epidemiology, 161, 1037-1046. (Pubitemid 40734352)
27. Lange, J. H., Mastrangelo, G., Fedeli, U., Fadda, E., Rylander, R., & Lee, E. (2003). Endotoxin exposure and lung cancer mortality by type of farming: Is there a hidden dose-response relationship? Annals of Agricultural and Environmental Medicine, 10, 229-232. (Pubitemid 38090051)
28. Mastrangelo, G., Marzia, V., Milan, G., Fadda, E., & Fedeli, U. (2004). An exposure-dependent reduction of lung cancer risk in dairy farmers: A nested case-referent study. Indoor and Built Environment, 13, 335-343.
29. Andersen, A., Barlow, L., Engeland, A., Kjaerheim, K., Lynge, E., & Pukkala, E. (1999). Work-related cancer in the Nordic countries. Scandinavian Journal of Work, Environment & Health, 25(suppl 2), 1-116.
30. Turunen, A. W., Verkasalo, P. K., Kiviranta, H., Pukkala, E., Jula, A., Männistö, S., et al. (2008). Mortality in a cohort with high fish consumption. International Journal of Epidemiology, 37, 1008-1017.
31. Mastrangelo, G., Fadda, E., Rylander, R., Milan, G., Fedell, U., Rossi di Schio, M., et al. (2008). Lung and other cancer site mortality in a cohort of Italian cotton mill workers. Occupational and Environmental Medicine, 65, 697-700.
32. Lange, J. H., Mastrangelo, G., & Thomulka, K. W. (2003). Will sewage workers with endotoxin related symptoms have the benefit of reduced lung cancer? Occupational and Environmental Medicine, 60, 144-145. (Pubitemid 36152833)
33. Laakkonen, A., Verkasalo, P. K., Nevalainen, A., Kauppinen, T., Kyyrönen, P., & Pukkala, E. (2008). Mould, bacteria and cancer among Finns: An occupational cohort study. Occupational and Environmental Medicine, 65, 489-493. (Pubitemid 351969699)
34. Hassler, S., Soininen, L., Sjölander, P., & Pukkala, E. (2008). Cancer among the Sami-A review on the Norwegian, Swedish and Finnish Sami populations. International Journal of Circumpolar Health, 67, 421-432.
35. Vijh, A. K. (2004). Inverse trend between estimated worldwide frequency of major cancers and inferred infectious burdens of populations: possible role of adaptive immune system. Med Hypotheses, 62, 880-888. (Pubitemid 38680352)
36. Fox, J. G., Beck, P., Dangler, C. A., Whary, M. T., Wang, T. C., Shi, H. N., et al. (2000). Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med, 6, 536-542. (Pubitemid 30305903)
37. Fox, J. G., & Wang, T. G. (2007). Inflammation, atrophy and gastric cancer. Journal of Clinical Investigation, 117, 60-69.
38. Whary, M. T., Sundina, N., Bravo, L. E., Correa, P., Quinones, F., Caro, F., et al. (2005). Intestinal helminthiasis in Columbian children promotes a Th2 responses for gastric carcinogenesis. Cancer Epidemiol Biomark Prev, 14, 1464-1469. (Pubitemid 40807347)
39. Tedeschi, A., & Airaghi, L. (2006). Is affluence a risk factor for bronchial asthma and type 1 diabetes? Pediatric Allergy and Immunology, 17, 533-537. (Pubitemid 44511089)
40. Savu, A., Potter, J., Li, S., & Yasui, Y. (2008). Breast cancer and microbial cancer incidence in female populations around the world: A surprising hyperbolic association. International Journal of Cancer, 123, 1094-1099.
41. Maizels, R. M., & Yazdananbakhsh, M. (2003). Immune regulation by helminth parasites: Cellular and molecular mechanisms. Nature Reviews. Immunology, 3, 733-743.
42. Pinheiro, P., Sherman, R., Trapido, E., Fleming, L., Huang, Y., Gomez-Marin, O., et al. (2009). Cancer incidence in first generation US Hispanics: Cubans, Mexicans, Puerto Ricans, and New Latinos. Cancer Epidemiol Biomark Prev, 18, 2162-2196.
43. Kalyoncu, A. F., & Stålenheim, G. (1992). Serum IgE levels and allergic spectra in immigrants in Sweden. Allergy, 47, 277-280.
44. Pance, A., Reisser, D., & Jeannin, J. F. (2002). Antitumoral effects of lipid A: Preclinical and clinical studies. Journal of Investigative Medicine, 50, 173-178. (Pubitemid 34522658)
45. Reisser, D., Pance, A., & Jeannin, J. F. (2002). Mechanisms of the anti-tumoral effect of lipid A. Bioessays, 24, 284-289.
46. Parvez, S., Malik, K., Kang, A., & Kim, H. Y. (2006). Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology, 100, 1171-1185. (Pubitemid 43739184)
47. Fichera, G. A., & Giese, G. (1994). Non-immunologically mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumor cell lines. Cancer Letters, 85, 93-103. (Pubitemid 24280168)
48. Akaza, H., Iwasaki, A., Ohtani, M., Ikeda, N., Niijima, K., Toida, I., et al. (1993). Expression of antitumor responses. Role of attachment and viability of Bacillus Calmette-Guerin to bladder cancer cells. Cancer, 72, 558-563. (Pubitemid 23193467)
49. Zheng, R., Jie, S., Hanchuan, D., & Moucheng, W. (2005). Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. International Immunopharmacology, 5, 811-820. (Pubitemid 40381115)
50. Krieg, A. M. (2008). Toll-like 9 (TLR 9) agonists in the treatment of cancer. Oncogene, 27, 161-167.
51. Juckett, D. A., Aylsworth, C. F., & Quensen, J. M. (2008). Intestinal protozoa are hypothesized to stimulate immunosurveillance against colon cancer. Med Hypotheses, 71, 104-110.
52. Otto, F., Schmid, P., MacKensen, A., Wehr, U., Seiz, A., Braun, M., et al. (1996). Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. European Journal of Cancer, 32A, 1712-1718. (Pubitemid 26306882)
53. Grange, J. M., Bottasso, O., Standford, C. A., & Standford, J. L. (2008). The use of mycobacterial adjuvant-based agents for immunotherapy of cancer. Vaccine, 26, 4984-4990.
54. Andreani, V., Gatti, G., Simonella, L., Rivero, V., & Maccioni, M. (2007). Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo. Cancer Research, 67, 10519-10527. (Pubitemid 350070828)
55. da Silva Correia, J., Miranda, Y., Austin-Brown, N., Hsu, J., Mathison, J., Xiang, R., et al. (2006). Nod1-dependent control of tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 103, 1840-1845. (Pubitemid 43228780)
56. Klymkowsky, M. W., & Savanger, P. (2009). Epithelialmesenchymal transition. A cancer researcher's conceptual friend and foe. Am J Pathol, 174, 1588-1593.
57. Berx, G., Raspe, E., Christofori, G., Thiery, J. P., & Sleeman, J. P. (2007). Pre-EMTingmetastasis? Recapitulation ofmorphogenetic processes in cancer. Clinical & Experimental Metastasis, 24, 587-597. (Pubitemid 50000849)
58. Ratajczak, M. Z., Shin, D. M., & Kucia, M. (2009). Very small embryonic/epiblast-like stem cells. A missing link to support the germ line hypothesis of cancer development? The American Journal of Pathology, 174, 1985-1992.
59. Chen, G. Y., & Núnez, G. (2009). Gut immunity: A NOD to the commensals. Current Biology, 19, R171-R174.
60. Cozen, W., Hamilton, A. S., Zhao, P., Salam, M., Deapen, D., Nathwani, B., et al. (2009). A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma. Blood, 114, 401419.
61. Cao, X. (2010). Regulatory T cells and immune tolerance to tumors. Immunol Res, 46(1-3), 79-93.
62. Zou, W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews. Immunology, 6, 295-307.
63. Gallimore, A. M., & Simon, A. K. (2008). Positive and negative influences of regulatory T cells on tumour immunity. Oncogene, 27, 5886-5893.
64. Afzali, B., Lombardi, G., Lechler, R. I., & Lord, G. M. (2007). The role of T helper 17 (Th17) and regulatory T cells (T reg) in human organ transplantation and autoimmune diseases. Clinical and Experimental Immunology, 148, 32-46. (Pubitemid 46365005)
65. Boniface, K., Blom, B., Liu, Y. J., & de Waal, M. R. (2008). From interleukin-23 to T-helper 17 cells: Human T-helper cell differentiation revisited. Immunological Reviews, 226, 132-146.
66. Mizuno, T., Ando, T., Nobata, K., Tsuzuki, T., Maeda, O., Watanabe, O., et al. (2005). Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World Journal of Gastroenterology, 11, 6305-6311. (Pubitemid 43013998)
67. Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham- Anderson, J., Wu, J., et al. (2007). Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature, 445, 648-651. (Pubitemid 46232884)
68. McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce- Saikh, B., Blumenschein, W. M., et al. (2009). The interleukin-23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nature Immunology, 10, 314-324.
69. Annunziato, F., & Romagnani, S. (2009). Do studies in humans better depict TH17 cells? Blood, 114, 2213-2219.
70. Wu, C., Wang, S., Wang, F., Chen, Q., Peng, S., Zhang, Y., et al. (2009). Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clinical and Experimental Immunology, 158, 1999-1204.
71. O'Carra, A., Stockinger, B., & Veldhoen, M. (2008). Differentiation of human Th17 cells does require TGF-β. Nature Immunology, 9, 588-590. (Pubitemid 351712629)
72. Zhou, L., Lopes, J. E., Chong, M., Ivanov, I., Min, R., Victora, G., et al. (2008). TGF-β induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORγt function. Nature, 453, 236-241.
73. Winer, S., Paltser, G., Chan, Y., Tsui, H., Engelman, E., Winer, D., et al. (2009). Obesity predisposes to Th17 bias. European Journal of Immunology, 39, 2629-2635.
74. van Kruijsdijk, R., van der Wall, E., & Visseren, F. (2009). Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prev, 18, 2569-2578.
75. Tato, C. M., & Cua, D. J. (2008). Reconciling id, ego, and superego within intreleukin-23. Immunological Reviews, 226, 103-111.
76. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., et al. (2007). Phenotypic and functional features of human Th17 cells. The Journal of Experimental Medicine, 204, 1849-1861. (Pubitemid 47240944)
77. Kolls, J., & Linden, A. (2004). Interleukin-17 family members and inflammation. Immunity, 21, 467-476. (Pubitemid 39370503)
78. Radhakrishnan, C., Cabrera, R., Schenk, E., Nava-Parada, P., Bell, M., van Keulen, V., et al. (2008). Reprogrammed Foxp3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. Journal of Immunology, 181, 3137- 3147.
79. Ayyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G., et al. (2009). Human memory Foxp3+ Tregs secrete IL-17 ex vivo and constitutively express the Th17 lineage-specific transcription factor RORgamma t. Proceedings of the National Academy of Sciences of the United States of America, 106, 8635-8640.
80. Zheng, S., Wang, J., & Horwitz, D. (2008). Foxp3+ CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. Journal of Immunology, 180, 7112-7116.
81. Martin-Orozco, N., & Dong, C. (2009). The IL-17/IL-23 axis of inflammation in cancer: Friend or foe? Curr Opin Investig Drugs, 10, 543-549.
82. Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., et al. (2009). Tumor-infiltrating Foxp3+T regulatory cells show strong prognostic significance in colorectal cancer. Journal of Clinical Oncology, 27, 186-192.
83. Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wel, S., et al. (2009). Phenotype, distribution, generation, functional and clinical relevance of Th17 cells in the human tumor environments. Blood, 114, 1141-1149.
84. Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K., Kaiser, A., et al. (2008). Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood, 112, 362-373.
85. Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., et al. (2006). IL-23 promotes tumour incidence and growth. Nature, 442, 461-465. (Pubitemid 44264796)
86. Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., et al. (2009). T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity, 31, 787-798.
87. Su, X., Ye, J., Hsueh, E., Zhang, Y., Hoft, D., & Peng, G. (2010). Tumor microenvironment direct the recruitment and expansion of human Th17 cells. Journal of Immunology, 184, 1630-1641.
88. Loddenkemper, C., Schernus, M., Noutsias, M., Stein, H., Thiel, E., & Nagorsen, D. (2006). In situ analysis of Foxp3+ regulatory T cells in human colorectal cancer. Journal of Translational Medicine, 4, 52.
89. Tzankov, A., Meier, C., Hirschmann, P., Went, P., Pileri, S. A., & Dirnhofer, S. (2008). Correlation of high numbers of intratumoral Foxp3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica, 93, 193-200. (Pubitemid 351397707)
90. Haas, M., Dimmler, A., Hohenberger, W., Grabenbauer, G. G., Niedobitek, G., & Distel, L. V. (2009). Stromal regulatory T cells are associated with favourable prognosis in gastric cancer of the cardia. BMC Gastroenterology, 9, 65.
91. Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., et al. (2005). CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in Apc Min/+ mice. Cancer Research, 65, 3998-4004. (Pubitemid 40775635)
92. Mocellin, S., Marincola, F. M., & Young, H. A. (2005). Interleukin-10 and the immune response against cancer: A counterpoint. Journal of Leukocyte Biology, 78, 1043-1051. (Pubitemid 41572467)
93. Massague, J. (2008). TGFβ in cancer. Cell, 134, 215-230.
94. Lin, W. W., & Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation and cancer. The Journal of Clinical Investigation, 117, 1175-1183. (Pubitemid 46718402)
95. Yang, L. (2010). TGFβ and cancer metastasis: An inflammation link. Cancer and Metastasis Reviews, 29, 263-271.
96. Clevers, H. (2004). At the crossroads of inflammation and cancer. Cell, 118, 671-674. (Pubitemid 39221727)
97. Yao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., et al. (2009). Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Natural Medicines, 15, 633-640.
98. Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Llacraz, S., et al. (2008). Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood, 112, 3696-3703.
99. Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGearchy, M. J., McClanahan, T. K., et al. (2009). Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signalling. The Journal of Experimental Medicine, 206, 535-548.
100. Schelbanie, A. T., Tadmori, I., Jing, H., Vassiliou, E., & Ganea, D. (2004). Prostaglandin E2 induces IL-23 production in bonemarrowderived dendritic cells. The FASEB Journal, 18, 1318-1320. (Pubitemid 39561589)
101. Schnurr, M., Toy, T., Shin, A., Wagner, M., Cebon, J., & Maraskovsky, E. (2005). Extracellular nucleotides signalling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: A novel role for the cAMP pathway. Blood, 105, 1582-1589. (Pubitemid 40223678)
102. Mulder, I., Schmidt, B., Stokes, C., Lewis, M., Bailey, M., Aminov, R., et al. (2009). Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces. BMC Biology, 7, 79.
103. Pagés, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautes- Fridman, C., & Fridman, W.-H. (2010). Immune infiltration in human tumors: A prognostic factor that should not be ignored. Oncogene, 29, 1093-1102.
104. Yang, L., & Moses, H. (2009). Transforming growth factor β: Tumor suppressor or promoter? Are host immune cells the answer? Cancer Research, 68, 9107-9111.
105. Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K., et al. (2006). Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell, 10, 99-111. (Pubitemid 44202603)
106. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagés, C., et al. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313, 1960-1964. (Pubitemid 44498003)
107. Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., et al. (2008). Stromal gene expression predicts clinical outcome in breast cancer. Natural Medicines, 14, 518-526.
108. Steidl, C., Lee, T., Shah, S., Farinha, P., Han, G., Nayar, T., et al. (2010). Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. New Engl J Med, 362, 875-885.
109. Hiraoka, K., Miyamoto, M., Suzuoki, M., Oshikiri, T., Nakakubo, Y., Itoh, T., et al. (2006). Concurrent infiltration by CD8+ T cells adn CD4+ Tcells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer, 94, 275-280. (Pubitemid 43151547)
110. Hubert, P., Jacobs, N., Caberg, J.-H., Boniver, J., & Delvenne, P. (2007). The cross-talk between dendritic and regulatory T cells: Good or evil? Journal of Leukocyte Biology, 82, 781-794. (Pubitemid 47511037)
111. Koch, M., Tucker-Heard, G., Perdue, N., Killebrew, J., Urdahl, K., & Campbell, D. (2009). The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunology, 10, 595-602.
112. Barnes, M., & Powrie, F. (2009). Hybrid T reg cells: Steel frames and plastic exteriors. Nature Immunology, 10, 563-564.
113. Kullberg, M., Jancovic, D., Gorelick, P., Caspar, P., Letterio, J., Cheever, A., et al. (2002). Bacteria-tiggered CD4+ T regulatory cells suppress Helicobacter hepaticus-induced colitis. The Journal of Experimental Medicine, 196, 505-515.
114. Erdman, S., Rao, V., Olipitz, W., Taylor, C., Jackson, E., Levkovich, T., et al. (2010). Unifying roles for regulatory T cells and inflammation in cancer. International Journal of Cancer, 126, 1651-1665.
115. Erdman, S., & Poutahidis, T. (2010). Cancer inflammation and regulatory T cells. International Journal of Cancer, 127, 768- 779.
116. Erdman, S., & Putahidis, T. (2010). Roles for inflammation and regulatory T cells in colon cancer. Toxicologic Pathology, 38, 76-87.
117. Fidler, I. (2003). The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nature Reviews. Cancer, 3, 1-6.
118. Mantovani, A. (2009). Inflaming metastasis. Nature, 457, 36-37.
119. Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007). Th17 cells in the circle of immunity and autoimmunity. Nature Immunology, 8, 345-350. (Pubitemid 46745409)
120. Rao, V., Poutahidas, T., Fox, J., & Erdman, S. (2007). Breast cancer: Should gastrointestinal bacteria be on our radar screen? Cancer Research, 67, 847-850.